Anew Health, a Hong Kong-based pain management and health services provider, lowered the proposed deal size for its upcoming IPO on Tuesday.
The company now plans to raise $9 million by offering 1.8 million shares at a price range of $4 to $6. It had previously filed to offer 3.8 million shares at the same range. At the midpoint, Anew Health will raise 52% in proceeds than previously anticipated.
Under its ANKH brand, Anew Health offers a broad range of non-surgical, non-invasive, and non-pharmacological pain management treatment and therapies, functional enhancement therapies, and health products. The company provides its pain management and function enhancement services via three service centers in Hong Kong.
Anew Health was founded in 2007 and booked $40 million in revenue for the 12 months ended March 31, 2025. It plans to list on the Nasdaq under the symbol AVG. D. Boral Capital is the sole bookrunner on the deal.
